NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS – PR Newswire

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS – PR Newswire
Source: Google NewsPublished on 2022-03-21